BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28303741)

  • 21. The estrogenic activity of resveratrol: a comprehensive review of
    Qasem RJ
    Crit Rev Toxicol; 2020 May; 50(5):439-462. PubMed ID: 32744480
    [No Abstract]   [Full Text] [Related]  

  • 22. New Approach Methodologies for the Endocrine Activity Toolbox: Environmental Assessment for Fish and Amphibians.
    Mitchell CA; Burden N; Bonnell M; Hecker M; Hutchinson TH; Jagla M; LaLone CA; Lagadic L; Lynn SG; Shore B; Song Y; Vliet SM; Wheeler JR; Embry MR
    Environ Toxicol Chem; 2023 Apr; 42(4):757-777. PubMed ID: 36789969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
    Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Review of Read-Across Potential in Testing for Endocrine-Related Effects in Vertebrate Ecological Receptors.
    McArdle ME; Freeman EL; Staveley JP; Ortego LS; Coady KK; Weltje L; Weyers A; Wheeler JR; Bone AJ
    Environ Toxicol Chem; 2020 Apr; 39(4):739-753. PubMed ID: 32030793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine disruptors affect larval zebrafish behavior: Testing potential mechanisms and comparisons of behavioral sensitivity to alternative biomarkers.
    Fraser TWK; Khezri A; Lewandowska-Sabat AM; Henry T; Ropstad E
    Aquat Toxicol; 2017 Dec; 193():128-135. PubMed ID: 29078070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo.
    Du G; Hu J; Huang H; Qin Y; Han X; Wu D; Song L; Xia Y; Wang X
    Environ Toxicol Chem; 2013 Feb; 32(2):353-60. PubMed ID: 23074026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals.
    Ankley GT; Jensen KM
    Environ Toxicol Chem; 2014 Nov; 33(11):2529-40. PubMed ID: 25098918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
    Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
    Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol.
    Frizzell C; Ndossi D; Kalayou S; Eriksen GS; Verhaegen S; Sørlie M; Elliott CT; Ropstad E; Connolly L
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):64-71. PubMed ID: 23665424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potential.
    Borgert CJ
    Crit Rev Toxicol; 2023 Feb; 53(2):53-68. PubMed ID: 37216681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose.
    Day P; Green RM; Gross M; Weltje L; Wheeler JR
    Toxicol Lett; 2018 Oct; 296():10-22. PubMed ID: 30006252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for bisphenol A-induced disruption of maternal thyroid homeostasis in the pregnant ewe at low level representative of human exposure.
    Guignard D; Gayrard V; Lacroix MZ; Puel S; Picard-Hagen N; Viguié C
    Chemosphere; 2017 Sep; 182():458-467. PubMed ID: 28521160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.
    Miller MM; McMullen PD; Andersen ME; Clewell RA
    Crit Rev Toxicol; 2017 Aug; 47(7):564-580. PubMed ID: 28675057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of petroleum streams for thyroid toxicity.
    Fowles JR; Banton MI; Boogaard PJ; Ketelslegers HB; Rohde AM
    Toxicol Lett; 2016 Jul; 254():52-62. PubMed ID: 27150732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances.
    Matthiessen P; Ankley GT; Biever RC; Bjerregaard P; Borgert C; Brugger K; Blankinship A; Chambers J; Coady KK; Constantine L; Dang Z; Denslow ND; Dreier DA; Dungey S; Gray LE; Gross M; Guiney PD; Hecker M; Holbech H; Iguchi T; Kadlec S; Karouna-Renier NK; Katsiadaki I; Kawashima Y; Kloas W; Krueger H; Kumar A; Lagadic L; Leopold A; Levine SL; Maack G; Marty S; Meador J; Mihaich E; Odum J; Ortego L; Parrott J; Pickford D; Roberts M; Schaefers C; Schwarz T; Solomon K; Verslycke T; Weltje L; Wheeler JR; Williams M; Wolf JC; Yamazaki K
    Integr Environ Assess Manag; 2017 Mar; 13(2):267-279. PubMed ID: 28127947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.
    Welshons WV; Thayer KA; Judy BM; Taylor JA; Curran EM; vom Saal FS
    Environ Health Perspect; 2003 Jun; 111(8):994-1006. PubMed ID: 12826473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endocrine effects of mercury in humans and wildlife.
    Tan SW; Meiller JC; Mahaffey KR
    Crit Rev Toxicol; 2009; 39(3):228-69. PubMed ID: 19280433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esterification of vertebrate like steroids in molluscs: a target of endocrine disruptors?
    Giusti A; Joaquim-Justo C
    Comp Biochem Physiol C Toxicol Pharmacol; 2013 Nov; 158(4):187-98. PubMed ID: 24004916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.